RETINOPATHY OF PREMATURITY IN AT-RISK POPULATION AT TERTIARY CARE HOSPITAL
Main Article Content
Keywords
Retinopathy of prematurity, infants, gestational age, birth weight, visual impairment
Abstract
Background: Retinopathy of prematurity (ROP) is a vision-threatening disease that primarily affects premature infants, especially those with low birth weight and low gestational age.
Objectives: This study aimed to investigate the prevalence and characteristics of ROP among infants admitted to a tertiary care hospital, where timely intervention and management are critical for preventing long-term visual impairment.
Study Design a Prospective Study.
Duration and Place of the study: This study was conducted at Combine Military Hospital (CMH), Quetta, between January 2022 to January 2023.
Material and Methods
Medical statistics of infants meeting the standards for being at risk of developing ROP were included in the study. Inclusion criteria comprised infants with a gestational age ≤ 32 weeks and birth weight ≤ 1500 grams, as per established guidelines for ROP screening. Demographic and clinical statistics were extracted from electronic medical records, which include gestational age, birth weight, gender, mode of delivery, presence of prenatal risk factors (e.g., maternal diabetes, hypertension), and postnatal complications (e.g., respiratory distress syndrome, sepsis). Ophthalmologic records pertaining to ROP analysis, stages, zones, and treatment modalities were also recorded.
Results: This study consisted of 98 infants who were diagnosed with ROP. The majority of the newborn babies were born between 29-32 weeks of gestation (74.5%) and had a birth weight between 1001-1500 grams (49.0%). There were slightly more male infants (53.1%) than female infants (46.9%). The most common mode of delivery was cesarean section (64.3%). The incidence and severity of ROP varied among the infants in the study.
Conclusion: This study determined that ROP is a common problem in premature infants, with an occurrence of 100%.
References
2. Reynolds JD. Retinopathy of prematurity (ROP). Pediatric Retina. 2010 Aug 19:85-116.
3. Koc E, Bas AY. Retinopathy of Prematurity (ROP): From the Perspective of the Neonatologist. Global Pediatrics. 2024 Feb 5:100159.
4. Bellini S. Retinopathy of Prematurity: Improving Outcomes Through Evidence‐Based Practice. Nursing for women's health. 2010 Oct;14(5):382-90.
5. Mechoulam H, Pierce EA. Retinopathy of prematurity: molecular pathology and therapeutic strategies. American Journal of Pharmacogenomics. 2003 Aug;3:261-77.
6. Hong EH, Shin YU, Cho H. Retinopathy of prematurity: a review of epidemiology and current treatment strategies. Clinical and Experimental Pediatrics. 2022 Mar;65(3):115.
7. Ojaghi H, Fekri Y, Momeni N, Amani F. Retinopathy of prematurity (ROP) in Ardebil (North West of Iran): Prevalence and Risk factors. Pakistan Journal of Medical and Health Sciences. 2021;15(5):1557-63.
8. Kumar P, Bhriguvanshi A, Singh SN, Kumar M, Tripathi S, Saxena S, Gupta SK. Retinopathy of prematurity in preterm infants: A prospective study of prevalence and predictors in Northern India. Clinical Epidemiology and Global Health. 2023 Mar 1;20:101230.
9. Ying GS, Quinn GE, Wade KC, Repka MX, Baumritter A, Daniel E, e-ROP Cooperative Group. Predictors for the development of referral-warranted retinopathy of prematurity in the telemedicine approaches to evaluating acute-phase retinopathy of prematurity (e-ROP) study. JAMA ophthalmology. 2015 Mar 1;133(3):304-11.
10. Trese MT, Droste PJ. Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity. Ophthalmology. 1998 Jun 1;105(6):992-7.
11. Uchida A, Miwa M, Shinoda H, Koto T, Nagai N, Mochimaru H, Tomita Y, Sasaki M, Ikeda K, Tsubota K, Ozawa Y. Association of maternal age to development and progression of retinopathy of prematurity in infants of gestational age under 33 weeks. Journal of Ophthalmology. 2014 Apr 30;2014.
12. Husain SM, Sinha AK, Bunce C, Arora P, Lopez W, Mun KS, Reddy MA, Adams GG. Relationships between maternal ethnicity, gestational age, birth weight, weight gain, and severe retinopathy of prematurity. The Journal of Pediatrics. 2013 Jul 1;163(1):67-72.
13. Uchida A, Miwa M, Shinoda H, Koto T, Nagai N, Mochimaru H, Tomita Y, Sasaki M, Ikeda K, Tsubota K, Ozawa Y. Association of maternal age to development and progression of retinopathy of prematurity in infants of gestational age under 33 weeks. Journal of Ophthalmology. 2014 Apr 30;2014.
14. Le C, Basani LB, Zurakowski D, Ayyala RS, Agraharam SG. Retinopathy of prematurity: Incidence, prevalence, risk factors, and outcomes at a tertiary care centre in Telangana. Journal of Clinical Ophthalmology and Research. 2016 Sep 1;4(3):119-22.
15. Binenbaum G, Ying GS, Quinn GE, Huang J, Dreiseitl S, Antigua J, Foroughi N, Abbasi S. The CHOP postnatal weight gain, birth weight, and gestational age retinopathy of prematurity risk model. Archives of Ophthalmology. 2012 Dec 1;130(12):1560-5.
16. Gonski S, Hupp SR, Cotten CM, Clark RH, Laughon M, Watt K, Hornik CP, Kumar K, Smith PB, Greenberg RG. Risk of development of treated retinopathy of prematurity in very low birth weight infants. Journal of Perinatology. 2019 Nov;39(11):1562-8.
17. Catanzarite V, Willms D, Wong D, Landers C, Cousins L, Schirmer D. Acute respiratory distress syndrome in pregnancy and the puerperium: causes, courses, and outcomes. Obstetrics & Gynecology. 2001 May 1;97(5):760-4.
18. Liang J. Systematic review and meta-analysis of the negative outcomes of retinopathy of prematurity treated with laser photocoagulation. European journal of ophthalmology. 2019 Mar;29(2):223-8.
19. Hwang CK, Hubbard GB, Hutchinson AK, Lambert SR. Outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology. 2015 May 1;122(5):1008-15.
20. Wallsh JO, Gallemore RP. Anti-VEGF-resistant retinal diseases: a review of the latest treatment options. Cells. 2021 Apr 29;10(5):1049.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Sara Mandokhel
PGR, FCPS Neurology, Quetta - Pakistan
Mehvish Mandokhail
PGR, FCPS, Pediatrics Department, CMH, Quetta - Pakistan
Arif Kibzai
Senior Register Pediatrics Department, Sandeman Provincial Hospital, Quetta - Pakistan
Zulfiqar Mandokhail
Final year MBBS Student in QIMS (Quetta Institute of Medical Sciences), Quetta - Pakistan
Zulfiqar Mandokhail
Final year MBBS Student in QIMS (Quetta Institute of Medical Sciences), Quetta - Pakistan
Sanaullah Jamali
PGR Pediatrics Department, Sandeman Provincial Hospital, Quetta - Pakistan
Ubaid Ullah
FCPS PGR Pediatrics Department, Bolan Medical College/ Hospital, Quetta - Pakistan
Mubina Aziz
Md House Officer, Qazi Hussain Ahmad Medical Complex, Nowshera - Pakistan